U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes